Chemical Compound
1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B
CAS Registry Number
13553-79-2
Primary record
1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B
- 库存
- 9,878 克
- 纯度
- 99.4 %
- CAS
- 13553-79-2
化合物标识与属性
- CAS
- 13553-79-2
- PubChem CID
- 6436726
- SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=O)C3=C(C2=O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)/C
- Canonical SMILES
- CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)C=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O
名称与同义词
- Rifamycin S
- Rifomycin S
- Rifampicin S
- rifamycin-S
- Rafamycin S
- Rifamycin S CRS
- 13553-79-2
- Rifaximin EP Impurity E
- RefChem:179427
- GlyTouCan:G05123TM
- PI53N820JV
- UNII-PI53N820JV
- RIFAMYCIN S [MI]
- MFCD06198807
- NSC 144130
- SCHEMBL415695
- EINECS 236-938-4
- BTVYFIMKUHNOBZ-ODRIEIDWSA-N
- NCI 144-130
- C37H45NO12
- CHEMBL236921
- DTXSID301043935
- SCHEMBL29618023
- CHEBI:34948
- 1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin
- BRN 0604802
- RIFAMYCIN S [EP IMPURITY]
- DTXCID601526374
- 1,4-Dideoxy-1,4-dioxo-rifamycin
- NSC-144130
- G05123TM
- MSK15202
- BBF-02633
- NSC144130
- s4425
- C37-H45-N-O12
- ZINC169660600
- CID6436726
- CS-O-02278
- Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-
- AN-15577
- FR151216
- LS-64233
- SC-19209
- SY235204
- 1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin
- RIFAXIMIN IMPURITY E [EP IMPURITY]
- FT-0654816
- A11758
- C14540
- 553R792
- RIFAMYCIN SODIUM IMPURITY B [EP IMPURITY]
- A1200356
- Q27116328
- (trihydroxy-methoxy-heptamethyl-tetraoxo-[?]yl) acetate
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate
- 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
- ((2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17,19-TRIHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,6,9,11-TETRAOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENAZANO)NAPHTHO(2,1-B)FURAN-21-YL ACETATE
- ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl) acetate
- 1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI); Rifomycin S (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 144130; Rifamycin S; Rifaximin Imp E (EP); Rifamycin Sodium Impurity B; Rifaximin Impurity E; Rifamycin Impurity B
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI)
- 236-938-4